Implications of protein structure instability: from physiological to pathological secondary structure

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• Protein folding is regulated by chaperones to prevent misfolding.
• Misfolded proteins can aggregate, forming amyloid structures.
• Amyloid aggregates cause diseases such as Alzheimer's, Parkinson's, and type II diabetes.

Purpose of the Study:

• To review recent studies on the origin of amyloid nucleation.
• To explore potential therapeutic strategies for amyloidosis.

Main Methods:

• Literature review of studies on protein folding, misfolding, and aggregation.
• Analysis of mechanisms underlying amyloid nucleation.
• Discussion of therapeutic prospects based on amyloidosis mechanisms.

Main Results:

• Identified common mechanisms in amyloid protein aggregation.
• Highlighted the need for further research into environmental factors influencing amyloidosis.
• Summarized current understanding of amyloid nucleation origins.

Conclusions:

• Elucidating amyloidosis mechanisms offers promising therapeutic avenues.
• Further research into environmental triggers for amyloid formation is crucial.
• Targeting protein aggregation pathways may lead to novel treatments for neurodegenerative diseases.